Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Peritoneal Oncology & HIPEC

Santiago González-Moreno

圣地亚哥·冈萨雷斯-莫雷诺

MD, PhD, FACS

🏢Hospital MD Anderson Cancer Center Madrid(马德里MD安德森癌症中心医院)🌐Spain

Chief of Surgical Oncology; Director, Peritoneal Surface Oncology Program外科肿瘤学主任;腹膜表面肿瘤学项目主任

44
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Santiago González-Moreno is Chief of Surgical Oncology at Hospital MD Anderson Cancer Center Madrid and founded Spain's foremost peritoneal surface oncology programme. Trained by Paul Sugarbaker, he established and led PSOGI as its president, driving international standardization of CRS + HIPEC quality, training, and research. He has published widely on outcomes, patient selection, and HIPEC drug protocols.

Share:

🧪Research Fields 研究领域

Peritoneal Surface Oncology腹膜表面肿瘤学
HIPEC腹腔热灌注化疗
Cytoreductive Surgery肿瘤减灭手术
Colorectal Peritoneal Metastases结直肠腹膜转移
Appendiceal Tumors阑尾肿瘤
Peritoneal Mesothelioma腹膜间皮瘤

🎓Key Contributions 主要贡献

PSOGI Leadership and International Standardization

Served as President of the Peritoneal Surface Oncology Group International (PSOGI), spearheading development of international consensus guidelines on CRS + HIPEC indications, quality standards, and training requirements adopted by over 50 countries.

Spanish National Peritoneal Oncology Program

Founded and directed Spain's national reference center for peritoneal malignancy at Hospital MD Anderson Madrid, training Spanish and Latin American surgeons and establishing the first Spanish prospective peritoneal malignancy registry.

HIPEC Drug Selection and Protocol Optimization

Conducted comparative studies of HIPEC drug protocols (mitomycin C vs. oxaliplatin) and perfusion techniques across colorectal, appendiceal, and gastric peritoneal malignancies, contributing evidence informing Spanish and international protocol guidelines.

Representative Works 代表性著作

[1]

Hyperthermic intraperitoneal chemotherapy: rationale and technique

World Journal of Gastrointestinal Oncology (2010)

Comprehensive technical review of HIPEC rationale, perfusion methods, and drug selection, widely cited as a reference for HIPEC program establishment.

[2]

Cytoreductive surgery and HIPEC in the management of peritoneal carcinomatosis from colorectal cancer: a systematic review

Annals of Surgical Oncology (2012)

Systematic review and meta-analysis synthesizing survival data from 24 studies, supporting CRS + HIPEC as superior to systemic therapy alone for colorectal peritoneal metastases.

[3]

PSOGI/EURACAN Clinical Practice Guidelines for Malignant Peritoneal Mesothelioma

European Journal of Surgical Oncology (2021)

International multidisciplinary guidelines co-authored through PSOGI defining diagnosis, staging, and treatment recommendations for malignant peritoneal mesothelioma across Europe.

🏆Awards & Recognition 奖项与荣誉

🏆PSOGI Presidential Award
🏆Spanish Society of Surgical Oncology (SEOQ) National Prize
🏆Hospital MD Anderson Cancer Center Madrid Scientific Excellence Award
🏆Latin American Society of Surgical Oncology (LASSO) International Collaboration Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 圣地亚哥·冈萨雷斯-莫雷诺 的研究动态

Follow Santiago González-Moreno's research updates

留下邮箱,当我们发布与 Santiago González-Moreno(Hospital MD Anderson Cancer Center Madrid)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment